PMDA drug package insert
ユナスピン静注用0.75g
PMDA Prescription drug · 株式会社ケミックス · package insert Sep 9, 2025
Key facts
| Brand names | ユナスピン静注用0.75g, ユナスピン静注用1.5g, ユナスピン静注用3g |
|---|---|
| Nonproprietary names | アンピシリンナトリウム・スルバクタムナトリウム |
| Companies | 製造販売元／株式会社ケミックス |
| Product type | Prescription drug |
| Therapeutic category | β-ラクタマーゼ阻害剤配合抗生物質製剤 |
| Therapeutic category codes | 876139 |
| YJ codes | 6139504F1030, 6139504F2053, 6139504F3084 |
| Approval numbers | 21700AMY00111000, 21700AMY00112000, 22700AMX00875000 |
| Package insert edition | 第3版 |
| Package insert date | Sep 9, 2025 |
| PMDA document key | 260054_6139504F1030_1 |
| PMDA company code | 260054 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: